These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 15512785)
1. Anti-insulin receptor autoantibodies are not required for type 2 diabetes pathogenesis in NZL/Lt mice, a New Zealand obese (NZO)-derived mouse strain. McInerney MF; Najjar SM; Brickley D; Lutzke M; Abou-Rjaily GA; Reifsnyder P; Haskell BD; Flurkey K; Zhang YJ; Pietropaolo SL; Pietropaolo M; Byers JP; Leiter EH Exp Diabesity Res; 2004; 5(3):177-85. PubMed ID: 15512785 [TBL] [Abstract][Full Text] [Related]
2. The diabetes-prone NZO/HlLt strain. I. Immunophenotypic comparison to the related NZB/BlNJ and NZW/LacJ strains. Haskell BD; Flurkey K; Duffy TM; Sargent EE; Leiter EH Lab Invest; 2002 Jul; 82(7):833-42. PubMed ID: 12118085 [TBL] [Abstract][Full Text] [Related]
3. Immune abnormalities in the diabetic New Zealand obese (NZO) mouse: insulin treatment partially suppresses splenic hyperactivity measured by flow cytometric analysis. Melez KA; Attallah AM; Harrison ET; Raveche ES Clin Immunol Immunopathol; 1985 Jul; 36(1):110-9. PubMed ID: 3891173 [TBL] [Abstract][Full Text] [Related]
4. Hyperglycemia, maturity-onset obesity, and insulin resistance in NONcNZO10/LtJ males, a new mouse model of type 2 diabetes. Cho YR; Kim HJ; Park SY; Ko HJ; Hong EG; Higashimori T; Zhang Z; Jung DY; Ola MS; Lanoue KF; Leiter EH; Kim JK Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E327-36. PubMed ID: 17616608 [TBL] [Abstract][Full Text] [Related]
5. Maternal environment and genotype interact to establish diabesity in mice. Reifsnyder PC; Churchill G; Leiter EH Genome Res; 2000 Oct; 10(10):1568-78. PubMed ID: 11042154 [TBL] [Abstract][Full Text] [Related]
6. Diabetes is associated with autoimmunity in the New Zealand obese (NZO) mouse. Melez KA; Harrison LC; Gilliam JN; Steinberg AD Diabetes; 1980 Oct; 29(10):835-40. PubMed ID: 7002665 [TBL] [Abstract][Full Text] [Related]
7. Hyperleptinemia, leptin resistance, and polymorphic leptin receptor in the New Zealand obese mouse. Igel M; Becker W; Herberg L; Joost HG Endocrinology; 1997 Oct; 138(10):4234-9. PubMed ID: 9322935 [TBL] [Abstract][Full Text] [Related]
8. Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Leiter EH; Reifsnyder PC Diabetes; 2004 Feb; 53 Suppl 1():S4-11. PubMed ID: 14749259 [TBL] [Abstract][Full Text] [Related]
9. Type 2 diabetes-like hyperglycemia in a backcross model of NZO and SJL mice: characterization of a susceptibility locus on chromosome 4 and its relation with obesity. Plum L; Kluge R; Giesen K; Altmüller J; Ortlepp JR; Joost HG Diabetes; 2000 Sep; 49(9):1590-6. PubMed ID: 10969845 [TBL] [Abstract][Full Text] [Related]
10. Blood pressure in 15 inbred mouse strains and its lack of relation with obesity and insulin resistance in the progeny of an NZO/HILtJ x C3H/HeJ intercross. Tsukahara C; Sugiyama F; Paigen B; Kunita S; Yagami K Mamm Genome; 2004 Dec; 15(12):943-50. PubMed ID: 15599552 [TBL] [Abstract][Full Text] [Related]
11. Impaired insulin action in adipocytes of New Zealand obese mice: a role for postbinding defects in pyruvate dehydrogenase and insulin mediator activity. Macaulay SL; Larkins RG Metabolism; 1988 Oct; 37(10):958-65. PubMed ID: 3050367 [TBL] [Abstract][Full Text] [Related]
12. Estrogen deficiency aggravates insulin resistance and induces β-cell loss and diabetes in female New Zealand obese mice. Vogel H; Mirhashemi F; Liehl B; Taugner F; Kluth O; Kluge R; Joost HG; Schürmann A Horm Metab Res; 2013 Jun; 45(6):430-5. PubMed ID: 23322514 [TBL] [Abstract][Full Text] [Related]
13. Diet-dependent obesity and hypercholesterolemia in the New Zealand obese mouse: identification of a quantitative trait locus for elevated serum cholesterol on the distal mouse chromosome 5. Giesen K; Plum L; Kluge R; Ortlepp J; Joost HG Biochem Biophys Res Commun; 2003 May; 304(4):812-7. PubMed ID: 12727230 [TBL] [Abstract][Full Text] [Related]
15. Differential endocrine responses to rosiglitazone therapy in new mouse models of type 2 diabetes. Leiter EH; Reifsnyder PC; Zhang W; Pan HJ; Xiao Q; Mistry J Endocrinology; 2006 Feb; 147(2):919-26. PubMed ID: 16254032 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiology and genetics of obesity and diabetes in the New Zealand obese mouse: a model of the human metabolic syndrome. Kluge R; Scherneck S; Schürmann A; Joost HG Methods Mol Biol; 2012; 933():59-73. PubMed ID: 22893401 [TBL] [Abstract][Full Text] [Related]
17. Nonbinding inhibitory antiinsulin receptor antibodies. A new type of autoantibodies in human diabetes. Boden G; Fujita-Yamaguchi Y; Shimoyama R; Shelmet JJ; Tappy L; Rezvani I; Owen OE J Clin Invest; 1988 Jun; 81(6):1971-8. PubMed ID: 2968369 [TBL] [Abstract][Full Text] [Related]
19. Hyperphagia, lower body temperature, and reduced running wheel activity precede development of morbid obesity in New Zealand obese mice. Jürgens HS; Schürmann A; Kluge R; Ortmann S; Klaus S; Joost HG; Tschöp MH Physiol Genomics; 2006 Apr; 25(2):234-41. PubMed ID: 16614459 [TBL] [Abstract][Full Text] [Related]
20. The genetic basis of obesity and type 2 diabetes: lessons from the new zealand obese mouse, a polygenic model of the metabolic syndrome. Joost HG Results Probl Cell Differ; 2010; 52():1-11. PubMed ID: 20865367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]